Tech Times on MSN
KRAS drug resistance has upstream cause: METTL13 enzyme fuels tumor protein overload
KRAS cancer treatment may have a new upstream target: the METTL13 enzyme that helps tumors overproduce KRAS protein and ...
Evolutionary changes in a key protein synthesis enzyme, isoleucyl-tRNA synthetase (IleRS), may help bacteria fine-tune how ...
A new review proposes that tRNA-derived small RNAs link chronic cellular stress to maladaptive translational remodeling in ...
A full genome sequence of Acinetobacter lwoffii DJPGP01, isolated from rice rhizosphere soil in India, reveals genes for ...
The metastatic outcome depends on the state of disseminated cancer cells (DCCs) leading to overt metastasis or undergoing ...
According to MarketsandMarkets™, the Lipid Nanoparticles Market is projected to reach USD 395.0 million by 2031, up from USD ...
Evolutionary changes in key protein synthesis enzyme, isoleucyl-tRNA synthetase (IleRS), may help bacteria fine-tune how quickly proteins are made ...
This Review Article examines artificial chemotaxis in micro/nanomotors, detailing mechanisms, experimental strategies, and collective behaviors. It highlights the need for standardized validation and ...
Bashkortostan is establishing the first full-cycle mRNA production infrastructure in Russia to shift personalized oncology ...
Part of $200 million multi-year investment strengthening the company's U.S. Electronics footprint, enabling further growth for the industry New 38,000-square-foot Sheboygan Falls, Wisconsin facility ...
Lipid Nanoparticles Market worth $395.0 million by 2031 - Exclusive Report by MarketsandMarkets DELRAY BEACH, Fla., Oct. 20, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Lipid Nanoparticle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results